Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation

Abstract The prevalence and dire implications of mutations in the tumour suppressor, p53, highlight its appeal as a chemotherapeutic target. We recently showed that impairing cellular antioxidant systems via inhibition of SLC7A11, a component of the system xc − cystine-glutamate antiporter, enhances...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Julia V. Milne, Bonnie Z. Zhang, Kenji M. Fujihara, Swati Dawar, Wayne A. Phillips, Nicholas J. Clemons
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ba9b4fb88cd4428c8a2cf11039b060f4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ba9b4fb88cd4428c8a2cf11039b060f4
record_format dspace
spelling oai:doaj.org-article:ba9b4fb88cd4428c8a2cf11039b060f42021-12-02T11:37:26ZTransketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation10.1038/s41598-021-83979-32045-2322https://doaj.org/article/ba9b4fb88cd4428c8a2cf11039b060f42021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83979-3https://doaj.org/toc/2045-2322Abstract The prevalence and dire implications of mutations in the tumour suppressor, p53, highlight its appeal as a chemotherapeutic target. We recently showed that impairing cellular antioxidant systems via inhibition of SLC7A11, a component of the system xc − cystine-glutamate antiporter, enhances sensitivity to mutant-p53 targeted therapy, APR-246. We investigated whether this synergy extends to other genes, such as those encoding enzymes of the pentose phosphate pathway (PPP). TKT, one of the major enzymes of the PPP, is allegedly regulated by NRF2, which is in turn impaired by accumulated mutant-p53 protein. Therefore, we investigated the relationship between mutant-p53, TKT and sensitivity to APR-246. We found that mutant-p53 does not alter expression of TKT, nor is TKT modulated directly by NRF2, suggesting a more complex mechanism at play. Furthermore, we found that in p53null cells, knockdown of TKT increased sensitivity to APR-246, whilst TKT overexpression conferred resistance to the drug. However, neither permutation elicited any effect on cells overexpressing mutant-p53 protein, despite mediating oxidative stress levels in a similar fashion to that in p53-null cells. In sum, this study has unveiled TKT expression as a determinant for sensitivity to APR-246 in p53-null cells.Julia V. MilneBonnie Z. ZhangKenji M. FujiharaSwati DawarWayne A. PhillipsNicholas J. ClemonsNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Julia V. Milne
Bonnie Z. Zhang
Kenji M. Fujihara
Swati Dawar
Wayne A. Phillips
Nicholas J. Clemons
Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation
description Abstract The prevalence and dire implications of mutations in the tumour suppressor, p53, highlight its appeal as a chemotherapeutic target. We recently showed that impairing cellular antioxidant systems via inhibition of SLC7A11, a component of the system xc − cystine-glutamate antiporter, enhances sensitivity to mutant-p53 targeted therapy, APR-246. We investigated whether this synergy extends to other genes, such as those encoding enzymes of the pentose phosphate pathway (PPP). TKT, one of the major enzymes of the PPP, is allegedly regulated by NRF2, which is in turn impaired by accumulated mutant-p53 protein. Therefore, we investigated the relationship between mutant-p53, TKT and sensitivity to APR-246. We found that mutant-p53 does not alter expression of TKT, nor is TKT modulated directly by NRF2, suggesting a more complex mechanism at play. Furthermore, we found that in p53null cells, knockdown of TKT increased sensitivity to APR-246, whilst TKT overexpression conferred resistance to the drug. However, neither permutation elicited any effect on cells overexpressing mutant-p53 protein, despite mediating oxidative stress levels in a similar fashion to that in p53-null cells. In sum, this study has unveiled TKT expression as a determinant for sensitivity to APR-246 in p53-null cells.
format article
author Julia V. Milne
Bonnie Z. Zhang
Kenji M. Fujihara
Swati Dawar
Wayne A. Phillips
Nicholas J. Clemons
author_facet Julia V. Milne
Bonnie Z. Zhang
Kenji M. Fujihara
Swati Dawar
Wayne A. Phillips
Nicholas J. Clemons
author_sort Julia V. Milne
title Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation
title_short Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation
title_full Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation
title_fullStr Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation
title_full_unstemmed Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation
title_sort transketolase regulates sensitivity to apr-246 in p53-null cells independently of oxidative stress modulation
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/ba9b4fb88cd4428c8a2cf11039b060f4
work_keys_str_mv AT juliavmilne transketolaseregulatessensitivitytoapr246inp53nullcellsindependentlyofoxidativestressmodulation
AT bonniezzhang transketolaseregulatessensitivitytoapr246inp53nullcellsindependentlyofoxidativestressmodulation
AT kenjimfujihara transketolaseregulatessensitivitytoapr246inp53nullcellsindependentlyofoxidativestressmodulation
AT swatidawar transketolaseregulatessensitivitytoapr246inp53nullcellsindependentlyofoxidativestressmodulation
AT wayneaphillips transketolaseregulatessensitivitytoapr246inp53nullcellsindependentlyofoxidativestressmodulation
AT nicholasjclemons transketolaseregulatessensitivitytoapr246inp53nullcellsindependentlyofoxidativestressmodulation
_version_ 1718395783709982720